HEMOSTASIS COAGULATION ROUTINE REAGENTS INSTRUMENTS T-TAS®01 INSTRUMENT

T-TAS® 01

Microfluidic chip system (AR, PL and HD Chip) to quantify the thrombus formation process under total blood flow conditions.

The T-TAS® 01 (Total Thrombus formation analysis system) provides a real-time, comprehensive, ex vivo assessment of blood haemostatic capacity.
It is composed of a portable instrument, a dedicated computer and a chip integrating chambers of flow covered with either collagen (PL Chip) to evaluate the primary hemostatic capacity (case of antiplatelet therapies or congenital platelet disorders),
a mixture of collagen and thromboplastin to assess primary and secondary hemostatic capacity (risk of bleeding) when platelet count is normal (AR Chip) or (HD Chip) if platelets are between 10,000 and 90,000/µL of blood to assess the risk of bleeding for thrombocytopenia and platelet transfusions.

Advantages

T-TAS® 01 is conformed with IVD CE marking.
Total thrombus formation analysis system for clinical use.
Single-use microchip produced by a precision injection molding technique requires only small-volume whole blood samples (approx. 320 μl).
Simple operation controlled by a dedicated computer system.

Informations

The formation of the platelet thrombus is a direct indicator of the primary hemostatic capacity of patients.
This test is performed under arterial flow conditions using whole blood samples anti-coagulated with benzylsulfonyl-D-ArgPro-4-amidinobenzylamide (BAPA).
BAPA is an anticoagulant that inhibits thrombin and Factor Xa, which blocks the coagulation cascade and allows the PL Chip test to specifically measure platelet thrombus formation (primary hemostasis).

Documentation

Download the product sheet

Price list, safety data sheets and notices are accessible to our registered customers.

Analyzers

References

25-18001	Instrument	1

During the test, the blood sample is exposed to arterial shear stresses in the presence of the collagen attached to the surface of the micro-capillary channels, which results in the binding of platelets to collagen in the presence of von Willebrand factor, and therefore the platelet activation.
Platelet activation results in the release of endogenous factors that recruit and activate other platelets and cause them to aggregate, or the formation of a platelet thrombus and its development. The formation of a platelet thrombus causes obstruction of the microcapillary channels, which increases the flow pressure within the test. Dimensions : (W x H x D) 320 x 247 x 360 mm Weight : 6.0 kg

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

You must identify yourself to search for a certificate of analysis